Structure of GPR101–Gs enables identification of ligands with rejuvenating potential-Reference-Cited by-同舟云学术

Structure of GPR101–Gs enables identification of ligands with rejuvenating potential

Published:2023-11-09 Issue: Volume: Page:
ISSN:1552-4450
Container-title:Nature Chemical Biology
language:en
Short-container-title:Nat Chem Biol

Author:

Yang Zhao,Wang Jun-Yan,Yang Fan,Zhu Kong-Kai,Wang Guo-Peng,Guan Ying,Ning Shang-Lei,Lu Yan,Li Yu^ORCID,Zhang Chao,Zheng Yuan,Zhou Shu-Hua,Wang Xin-Wen,Wang Ming-Wei,Xiao Peng^ORCID,Yi Fan^ORCID,Zhang Cheng,Zhang Peng-Ju,Xu Fei^ORCID,Liu Bao-Hua^ORCID,Zhang Hua,Yu Xiao^ORCID,Gao Ning^ORCID,Sun Jin-Peng^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Cell Biology,Molecular Biology

Link

https://www.nature.com/articles/s41589-023-01456-6.pdf

Reference49 articles.

1. Meye, F. J., Ramakers, G. M. & Adan, R. A. The vital role of constitutive GPCR activity in the mesolimbic dopamine system. Transl. Psychiatry 4, e361 (2014).

2. Sando, R. & Sudhof, T. C. Latrophilin GPCR signaling mediates synapse formation. eLife https://doi.org/10.7554/eLife.65717 (2021).

3. Xiao, X. et al. A new understanding of GHSR1a—independent of ghrelin activation. Ageing Res Rev. 64, 101187 (2020).

4. Tao, Y. X. Constitutive activation of G protein-coupled receptors and diseases: insights into mechanisms of activation and therapeutics. Pharmacol. Ther. 120, 129–148 (2008).

5. Bond, R. A. & Ijzerman, A. P. Recent developments in constitutive receptor activity and inverse agonism, and their potential for GPCR drug discovery. Trends Pharmacol. Sci. 27, 92–96 (2006).

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. DeFuseDTI: Interpretable drug target interaction prediction model with dual-branch encoder and multiview fusion;Future Generation Computer Systems;2024-12

2. GPR176 promotes fibroblast-to-myofibroblast transition in organ fibrosis progression;Biochimica et Biophysica Acta (BBA) - Molecular Cell Research;2024-10

3. Chromatin conformation capture in the clinic: 4C-seq/HiC distinguishes pathogenic from neutral duplications at the GPR101 locus;Genome Medicine;2024-09-13

4. Computational Methods for the Discovery and Optimization of TAAR1 and TAAR5 Ligands;International Journal of Molecular Sciences;2024-07-27

5. The sphingosine-1-phosphate receptor 1 mediates the atheroprotective effect of eicosapentaenoic acid;Nature Metabolism;2024-06-21